Khazardoost 2011 (V25).

Methods	Participants were "randomised". No other details available.
Participants	60 women at term with intact membranes and BS < 6.
Interventions	A single dose of oral misoprostol 100 mcg or vaginal misoprostol 25 mcg
Outcomes	Delivery outcomes. Neonatal outcomes. Maternal side effect outcomes.
Notes	Data on oxytocin augmentation were excluded due to translation error.
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Insufficient information about the sequence generation process to permit judgement of ‘Low risk’ or ‘High risk’.
Allocation concealment (selection bias)	Unclear risk	B ‐ Unclear.
Incomplete outcome data (attrition bias) All outcomes	Unclear risk	The study did not address this outcome.
Selective reporting (reporting bias)	Unclear risk	Insufficient information to permit judgement of ‘Low risk’ or ‘High risk’.
Other bias	Unclear risk	Insufficient information to assess whether an important risk of bias exists.
Blinding of participants and personnel (performance bias) All outcomes	Unclear risk	Insufficient information to permit judgement of ‘Low risk’ or ‘High risk’.
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Insufficient information to permit judgement of ‘Low risk’ or ‘High risk’.